A175 REAL-WORLD EXPERIENCE ON SWITCHING FROM ADALIMUMAB TO BIOSIMILARS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – AN OBSERVATIONAL STUDY FROM THREE TERTIARY CARE CENTRES

por Bedi, H, Rosenfeld, D, Hoang, T, Reise-Filteau, M, Bressler, B, Leung, Y, Singh, S, Rosenfeld, G
Publicado 2023